4.7 Article

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Journal

CELL HOST & MICROBE
Volume 29, Issue 5, Pages 819-+

Publisher

CELL PRESS
DOI: 10.1016/j.chom.2021.03.005

Keywords

-

Funding

  1. National Institutes of Health (NIH) [P30 GM124165]
  2. US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]
  3. Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID)
  4. COVID-19 Fast Grants
  5. Self Graduate Fellowship Program
  6. NIH [DP5OD023118, R21AI143407, R21AI144408]
  7. Simons Foundation [SF349247]
  8. NYSTAR
  9. NIH National Institute of General Medical Sciences [GM103310, GM129539]
  10. Brii Biosciences
  11. Jack Ma Foundation
  12. JBP Foundation

Ask authors/readers for more resources

Structural analysis revealed that seven potent NTD-directed neutralizing antibodies target a common surface on NTD, forming a single supersite different from the recognition pattern of RBD-directed antibodies.
Numerous antibodies that neutralize SARS-CoV-2 have been identified, and these generally target either the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the viral spike. While RBD-directed antibodies have been extensively studied, far less is known about NTD-directed antibodies. Here, we report cryo-EM and crystal structures for seven potent NTD-directed neutralizing antibodies in complex with spike or isolated NTD. These structures defined several antibody classes, with at least one observed in multiple convalescent donors. The structures revealed that all seven antibodies target a common surface, bordered by glycans N17, N74, N122, and N149. This site-formed primarily by a mobile beta-hairpin and several flexible loops-was highly electropositive, located at the periphery of the spike, and the largest glycan-free surface of NTD facing away from the viral membrane. Thus, in contrast to neutralizing RBD-directed antibodies that recognize multiple non-overlapping epitopes, potent NTD-directed neutralizing antibodies appear to target a single supersite.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available